SLC6A4 and depressive disorder: The serotonin transporter (5-HTT) regulates serotonin (5-HT) availability at the synapse, and is the target of selective serotonin reuptake inhibitors (SSRIs), which are currently the mainline treatment for depression and anxiety disorders.